课题基金 / 基金详情

TRAINING PROGRAM FOR MEDICAL SCIENTISTS

TRAINING PROGRAM FOR MEDICAL SCIENTISTS
医学科学家培训计划
批准号:
10652415
负责人:
Nancy Demore
金额:
$80.31万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-07-01 至 2025-06-30

项目摘要

项目成果

Nancy Demore的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 本申请要求继续支持医科大学的医学科学家培训计划 来自南卡罗来纳州。主要目标是培养下一代的医生科学家谁将选择职业 该中心将进行基础科学和临床科学相结合的研究,以改善人类健康, 疾病该计划最初成立于1980年,并稳步增长到目前的56名学生, 女性占32%,少数族裔占11%。在这136名校友中,6名是教授,3名持有 10名副教授,21名助理教授,6名从事工业研究,1名在 美国国立卫生研究院,2人在弗吉尼亚州,8人是临床教师(助理教授),27人在私人执业,52人仍然 在训练中,1人身份不明,2人死亡。我们的2018年申请人库是有史以来最大的,有208份申请。超过 过去5年(2013-2018年),平均申请人数为189人/年,而上一个5年 平均每年152人,增长24%。我们的实习生候选人库的增加反映了 MUSC优越的研究环境、MSTP学生的杰出成就以及 该计划的国家招聘工作,其中包括个人联系和招聘信与小册子 发送给参加MCAT并获得>514或更高分数的学生。质量的提高, 我们的申请人数为每年10个职位的要求提供了基础。我们的医疗计划 学校正在向综合弹性课程转变。在这个课程中,前两年将被浓缩成 18个月,有频繁的短期假期。新的预科(FLEX)课程将增加灵活性, 研究生重新进入医学院。 除了严格的基础科学研究培训和 医学院,学员通过转化科学诊所获得转化研究的经验,一个月 在Research Nexus和转化医学研讨会系列中。下一阶段的目标是: 1)通过合作和高度合作,继续在生物医学研究领域进行严格的研究培训。 具有出色的培训和研究记录的有成就的教师,2)提供培训计划, 挑战学生独立思考和批判性,3)在一个具有挑战性的,互动的培训 环境,包括基础,临床和转化科学,4)利用个性化的发展计划 为了增强培训经验,5)继续对使用这两种方法的计划进行严格和正式的评估 定量和定性数据,以确保最严格,有效和高效的培训,以及6)研究所 创业培训。
英文摘要
PROJECT SUMMARY / ABSTRACT This application requests continued support of the Medical Scientist Training Program at the Medical University of South Carolina. The major goal is to train the next generation of physician-scientists who will choose a career that will conduct research that integrates both the basic and clinical sciences to improve human health and treat diseases. The program was originally founded in 1980 and has steadily grown to its current size of 56 students, with 32% females and 11% underrepresented minorities. Of these 136 alumni, 6 are Professors, 3 holding endowed chairs, 10 associate professors, 21 assistant professors, 6 conduct research in industry, 1 is at the NIH, 2 are at the VA, 8 are clinical faculty (instructor-assistant professor), 27 in private practice, 52 still in training, 1 unknown and 2 deceased. Our 2018 applicant pool is the largest ever with 208 applications. Over the past 5 years (2013-2018) the average number of applicants has been 189/yr, compared to the previous 5-yr average of 152/yr, which is a 24% increase. This increase in our trainee candidate pool reflects a combination of MUSC’s exceptional research environment, our MSTP students’ outstanding accomplishments, and the program’s national recruitment efforts, which includes personal contacts and a recruitment letter with brochure sent to students who took the MCAT and received a score of >514 or better. The growth in the quality and quantity of our applicants provides the basis for the requested 10 positions per year. Our program in the medical school is changing to an integrated flex curriculum. In this curriculum, the first two years will be condensed into 18 months, with frequent short vacations. The new preclerkship (FLEX) curriculum will increase flexibility for graduate students to re-enter into medical school. In addition to rigorous basic science research training and medical school, trainees gain experiences in translational research via the Translational Sciences Clinic, a month in the Research Nexus and the Translational Medicine Seminar series. The objectives for the next phase are to: 1) continue the rigorous research training in areas of biomedical research by collaborative and highly accomplished faculty with exceptional records of training and research, 2) offer a training program that challenges students to think independently and critically, 3) conduct the training in a challenging, interactive environment that embraces basic, clinical and translational sciences, 4) utilize individualized development plans to enhance the training experience, 5) continue the rigorous and formal evaluation of the program that uses both quantitative and qualitative data to ensure the most rigorous, effective and efficient training, and 6) institute entrepreneurship training.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SFRP2 and NFAT are Therapeutic Targets in Angiosarcoma
SFRP2 and NFAT are therapeutic targets in angiosarcoma
SFRP2 and NFAT are therapeutic targets in angiosarcoma
SFRP2 and NFAT are therapeutic targets in angiosarcoma
海外基金